Improving Medicaid Precision and Cancer Test Act of 2025
Sponsored By: Representative Gottheimer
Introduced
Summary
This bill would require Medicaid to cover lung cancer biomarker testing nationwide starting January 1, 2027. It adds the test to the list of mandatory Title XIX services so states must include it in their Medicaid plans.
Show full summary
- Families and patients: Medicaid enrollees diagnosed with lung cancer would have Medicaid-covered biomarker testing beginning January 1, 2027.
- State Medicaid programs: State plans would be required to add lung cancer biomarker testing to the enumerated mandatory benefits under Title XIX.
- Clinicians and laboratories: Providers and labs serving Medicaid patients would see coverage of these tests become an explicit federal requirement, supporting billing and access across participating states.
Your PRIA Score
Personalized for You
How does this bill affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
Medicaid would cover lung cancer tests
If enacted, State Medicaid plans would have to cover lung cancer biomarker testing. Coverage would start January 1, 2027. This would help Medicaid enrollees who need this test. The bill text does not specify changes to copays, premiums, or funding.
Sponsors & CoSponsors
Sponsor
Gottheimer
NJ • D
Cosponsors
Rutherford
FL • R
Sponsored 11/28/2025
Swalwell
CA • D
Sponsored 12/15/2025
Grijalva
AZ • D
Sponsored 2/3/2026
Roll Call Votes
No roll call votes available for this bill.
View on Congress.govTake It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in